Liu C, Hu S, Xu X, Zhang Y, et al. Evaluation of tumour heterogeneity by (18)F-fluoroestradiol PET as a predictive measure in breast cancer patients receiving palbociclib combined with endocrine treatment. Breast Cancer Res 2022;24:57.
PMID: 36028895